BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8816805)

  • 1. The role of CD4-Lck in T-cell receptor antagonism: evidence for negative signaling.
    Racioppi L; Matarese G; D'Oro U; De Pascale M; Masci AM; Fontana S; Zappacosta S
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10360-5. PubMed ID: 8816805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor.
    Vignali DA; Strominger JL
    J Exp Med; 1994 Jun; 179(6):1945-56. PubMed ID: 7515103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of lck and loss of TCR-mediated signaling upon persistent engagement with complexes of peptide:MHC molecules.
    Lee JE; Cossoy MB; Chau LA; Singh B; Madrenas J
    J Immunol; 1997 Jul; 159(1):61-9. PubMed ID: 9200439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of T cell receptor-mediated Th1 cell IFN-gamma production and proliferation by divergent cAMP-mediated redox pathways.
    Cochrane R; Clark RB; Huang CK; Cone RE
    J Interferon Cytokine Res; 2001 Oct; 21(10):797-807. PubMed ID: 11710991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive CD4 cross-linking inhibits T cell activation by anti-receptor antibody but not by antigen.
    Dianzani U; Shaw A; Fernandez-Cabezudo M; Janeway CA
    Int Immunol; 1992 Sep; 4(9):995-1001. PubMed ID: 1390442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p56lck SH2 domain mediates recruitment of CD8/p56lck to the activated T cell receptor/CD3/zeta complex.
    Thome M; Germain V; DiSanto JP; Acuto O
    Eur J Immunol; 1996 Sep; 26(9):2093-2100. PubMed ID: 8814252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
    Tamir A; Granot Y; Isakov N
    J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant TCR-mediated signaling in CD45-null thymocytes involves dysfunctional regulation of Lck, Fyn, TCR-zeta, and ZAP-70.
    Stone JD; Conroy LA; Byth KF; Hederer RA; Howlett S; Takemoto Y; Holmes N; Alexander DR
    J Immunol; 1997 Jun; 158(12):5773-82. PubMed ID: 9190928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of intracellular signaling pathways in response to partial agonist ligands of the T cell receptor.
    Chau LA; Bluestone JA; Madrenas J
    J Exp Med; 1998 May; 187(10):1699-709. PubMed ID: 9584148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospho-LAT-independent activation of the ras-mitogen-activated protein kinase pathway: a differential recruitment model of TCR partial agonist signaling.
    Chau LA; Madrenas J
    J Immunol; 1999 Aug; 163(4):1853-8. PubMed ID: 10438919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists.
    Madrenas J; Wange RL; Wang JL; Isakov N; Samelson LE; Germain RN
    Science; 1995 Jan; 267(5197):515-8. PubMed ID: 7824949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine kinase activity of CD4-associated p56lck may not be required for CD4-dependent T-cell activation.
    Collins TL; Burakoff SJ
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11885-9. PubMed ID: 7505449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The catalytic domain of pp56(lck), but not its regulatory domain, is sufficient for inducing IL-2 production.
    Carrera AC; Calvo V; Borlado LR; Paradis H; Alemany S; Roberts TM; Martinez-A C
    J Immunol; 1996 Nov; 157(9):3775-82. PubMed ID: 8892605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of CD4:lck with the T cell receptor/CD3 complex induces early signaling events in the absence of CD45 tyrosine phosphatase.
    Deans JP; Kanner SB; Torres RM; Ledbetter JA
    Eur J Immunol; 1992 Mar; 22(3):661-8. PubMed ID: 1532148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EMT/ITK/TSK (EMT) tyrosine kinase is activated during TCR signaling: LCK is required for optimal activation of EMT.
    Gibson S; August A; Kawakami Y; Kawakami T; Dupont B; Mills GB
    J Immunol; 1996 Apr; 156(8):2716-22. PubMed ID: 8609388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional uncoupling of T-cell receptor engagement and Lck activation in anergic human thymic CD4+ T cells.
    Fujimaki W; Iwashima M; Yagi J; Zhang H; Yagi H; Seo K; Imai Y; Imanishi K; Uchiyama T
    J Biol Chem; 2001 May; 276(20):17455-60. PubMed ID: 11279170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A kinase-independent function of Lck in potentiating antigen-specific T cell activation.
    Xu H; Littman DR
    Cell; 1993 Aug; 74(4):633-43. PubMed ID: 8358792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal signal transduction through CD4 leads to altered tyrosine phosphorylation in T cells derived from MRL-lpr/lpr mice.
    Duan JM; Fagard R; Madaio MP
    Autoimmunity; 1996; 23(4):231-43. PubMed ID: 8915030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S-acylation of LCK protein tyrosine kinase is essential for its signalling function in T lymphocytes.
    Kabouridis PS; Magee AI; Ley SC
    EMBO J; 1997 Aug; 16(16):4983-98. PubMed ID: 9305640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A monoclonal antibody specific for a cytochrome c T cell stimulatory peptide inhibits T cell responses and affects the way the peptide associates with antigen-presenting cells.
    Jemmerson R; Johnson JG; Burrell E; Taylor PS; Jenkins MK
    Eur J Immunol; 1991 Jan; 21(1):143-51. PubMed ID: 1846813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.